
3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downturn
2026-05-12 08:02:543B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s current price of ₹1,250.40 reflects a 3.41% decline from the previous close, underscoring growing investor caution amid deteriorating technical signals and a downgrade in its Mojo Grade from Hold to Sell.
Read More
3B Blackbio DX Ltd is Rated Sell
2026-05-07 10:11:233B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-07 08:02:063B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has recently exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a 2.88% gain on 7 May 2026, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and lingering downside risks.
Read More
3B Blackbio DX Ltd is Rated Sell
2026-04-26 10:10:243B Blackbio DX Ltd is rated Sell by MarketsMOJO. This rating was last updated on 23 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 26 April 2026, providing investors with the latest perspective on the company’s position.
Read More
3B Blackbio DX Ltd is Rated Sell
2026-04-15 10:10:343B Blackbio DX Ltd is rated Sell by MarketsMOJO. This rating was last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More3B Blackbio DX Ltd Gains 2.41%: Technical Signals and Market Moves This Week
2026-04-11 17:09:19Key Events This Week 6 Apr: Week opens at Rs.1,194.00 7 Apr: Death Cross formation signals potential bearish trend 8 Apr: Technical momentum deteriorates; stock rebounds +4.20% 9 Apr: Price dips amid mixed market sentiment 10 Apr: Week closes at Rs.1,222.75 (+2.41% weekly gain) Week OpenRs.1,194.00 <div ...
Read More
3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downturn
2026-04-08 08:01:073B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is reflected across multiple technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment as the stock price continues to struggle below key resistance levels.
Read More
3B Blackbio DX Ltd Forms Death Cross, Signalling Potential Bearish Trend
2026-04-07 18:00:243B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about sustained weakness in the near to medium term.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
03-Jun-2026 | Source : BSETranscript of Analysts/Investors Call pertaining to the Financial Results for the quarter and Financial Year ended March 31 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
01-Jun-2026 | Source : BSEAudio Recording of Analysts/Investors Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSESubmission of Newspaper Publication
Corporate Actions
No Upcoming Board Meetings
3B Blackbio DX Ltd has declared 40% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available
